Tag: Loopt

Browse our exclusive articles!

ChatGPT CEO Pushes for Headquarters in Europe

OpenAI's CEO Sam Altman is scouting for a European office in compliance with upcoming EU regulations. The decision will impact AI regulation enforcement.

Sam Altman, CEO of OpenAI, to Discuss Future of AI in Seoul Event Co-hosted by SoftBank Ventures

OpenAI CEO Sam Altman to discuss the future of AI and engage with enthusiasts in Seoul. Co-hosted by SoftBank Ventures and the Ministry of SMEs and Startups.

CEOs warn that AI could pose risk comparable to nuclear war

The CEOs of OpenAI, DeepMind, and Anthropic are warning of the extinction risk posed by artificial intelligence. The Center for AI Safety compared it to nuclear war and pandemics.

ChatGPT Developer Calls for International Regulation of Powerful Artificial AI

Sam Altman, co-chairman of OpenAI, proposes to form an international body to oversee Artificial Intelligence advancements in order to ensure absolute safety when deploying advanced technologies. This organization is similar to the International Atomic Energy Agency for the AI sector and will bring new regulations for AI-based projects. Joe Biden’s EPA takeover of the US automotive industry makes Sam’s propositions even more relevant.

Who is Sam Altman and How His Work at OpenAI and ChatGPT is Impacting the World?

OpenAI is an artificial intelligence research and implementation organization driven to create technologies to benefit the world. Co-founded by Sam Altman, a 38-year-old American CEO, and Elon Musk, OpenAI develops AI tools like ChatGPT and DALL-E. Sam Altman recently testified in the US Congress, expressing concern over the potential consequences if AI were to go wrong, while stressing its potential beneficial impacts. Read the article to discover more about OpenAI and their mission to make a better world with AI.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img